When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Here's Why Karyopharm Therapeutics Is Sliding on Tuesday
Karyopharm Therapeutics Inc.
Shares of Karyopharm Therapeutics (NASDAQ: KPTI) , a biopharmaceutical company developing new cancer drugs, are tanking Tuesday as investors respond to an unexpected leadership change.
The stock was trading 30.5% lower as of 11:52 a.m. ET.
On Feb. 8, shares of Karyopharm slipped after the company posted lackluster clinical trial results for its lead drug, Xpovio, as a potential treatment for endometrial cancer. The drug is already approved to treat multiple myeloma patients whose conditions worsen despite previous lines of treatment.